Catherine Moukheibir's most recent trade in MoonLake Immunotherapeutics - Ordinary Shares - Class A was a trade of 23,500 Option to Buy done . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2025 | 23,500 | 21,500 | - | - | Option to Buy | |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Sale of securities on an exchange or to another person at price $ 48.79 per share. | 03 Jul 2025 | 23,500 | 0 | - | 48.8 | 1,146,565 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2025 | 23,500 | 23,500 | - | 0 | Class A ordinary shares, par value $0.0001 per share | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 45,000 | 117,944 (0%) | 0% | 0 | Class A Common Stock | |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 6,682 | 6,682 | - | - | Option to Buy | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,311 | 72,944 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Sale of securities on an exchange or to another person at price $ 6.36 per share. | 06 Jun 2024 | 44,426 | 84,207 (0%) | 0% | 6.4 | 282,549 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Sale of securities on an exchange or to another person at price $ 6.61 per share. | 06 Jun 2024 | 35,574 | 48,633 (0%) | 0% | 6.6 | 235,144 | Class A Common Stock |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,688 | 7,688 | - | - | Option to Buy | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,572 | 128,633 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 22,350 | 124,963 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 1,586 | 102,613 (0%) | 0% | 0 | Class A Common Stock | |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 11,297 | 11,297 | - | - | Option to Buy | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 1,677 | 101,027 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 21,571 | 99,350 (0%) | 0% | 0 | Class A Common Stock | |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 45,000 | 45,000 | - | - | Option to Buy | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 1,466 | 77,779 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 1,541 | 76,313 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2021 | 1,447 | 74,772 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 22,766 | 71,760 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 1,573 | 48,994 (0%) | 0% | 0 | Class A Common Stock |